Phase II trial of lapatinib and topotecan (LapTop) in patients with platinum-refractory/resistant ovarian and primary peritoneal carcinoma

S. John Weroha, Ann L. Oberg, Katie L.Allen Ziegler, Shaker R. Dakhilm, Kendrith M. Rowland, Lynn C. Hartmann, Dennis F. Moore, Gary L. Keeney, Prema P. Peethambaram, Paul Haluska

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Phase II trial of lapatinib and topotecan (LapTop) in patients with platinum-refractory/resistant ovarian and primary peritoneal carcinoma'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry